These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35231899)

  • 1. Heparin in the treatment of aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Lukito PP; Lie H; Helsa K; July J
    Neurosurg Focus; 2022 Mar; 52(3):E9. PubMed ID: 35231899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin Treatment in Aneurysmal Subarachnoid Hemorrhage: A Review of Human Studies.
    Khattar NK; Bak E; White AC; James RF
    Acta Neurochir Suppl; 2020; 127():15-19. PubMed ID: 31407057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
    Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T
    J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Burden of Angiographic Vasospasm and Its Complications After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review.
    Chalet FX; Briasoulis O; Manalastas EJ; Talbot DA; Thompson JC; Macdonald RL
    Neurol Ther; 2023 Apr; 12(2):371-390. PubMed ID: 36609962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
    World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose versus Therapeutic Range Intravenous Unfractionated Heparin Prophylaxis in the Treatment of Patients with Severe Aneurysmal Subarachnoid Hemorrhage After Aneurysm Occlusion.
    Kunz M; Siller S; Nell C; Schniepp R; Dorn F; Huge V; Tonn JC; Pfister HW; Schichor C
    World Neurosurg; 2018 Sep; 117():e705-e711. PubMed ID: 29959066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
    BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy and outcomes after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
    Garton ALA; Berger K; Merkler AE; Kamel H; Knopman J; Zhang C; Murthy SB
    Clin Neurol Neurosurg; 2023 Dec; 235():108025. PubMed ID: 37925994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Mao G; Gigliotti MJ; Esplin N; Sexton K
    Clin Neurol Neurosurg; 2021 Mar; 202():106546. PubMed ID: 33588359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction.
    Kole MJ; Wessell AP; Ugiliweneza B; Cannarsa GJ; Fortuny E; Stokum JA; Shea P; Chryssikos T; Khattar NK; Crabill GA; Schreibman DL; Badjatia N; Gandhi D; Aldrich EF; James RF; Simard JM
    Neurosurgery; 2021 Feb; 88(3):523-530. PubMed ID: 33269390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional 'H' therapy in vasospasm treatment.
    Bruder M; Won SY; Kashefiolasl S; Wagner M; Brawanski N; Dinc N; Seifert V; Konczalla J
    J Neurointerv Surg; 2017 Jul; 9(7):659-663. PubMed ID: 28153852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment.
    Simard JM; Aldrich EF; Schreibman D; James RF; Polifka A; Beaty N
    J Neurosurg; 2013 Dec; 119(6):1611-9. PubMed ID: 24032706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review.
    Stuart D; Christian R; Uschmann H; Palokas M
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):2013-2026. PubMed ID: 30335041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review.
    Solar P; Mackerle Z; Joukal M; Jancalek R
    Neurosurg Rev; 2021 Apr; 44(2):649-658. PubMed ID: 32124117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Song J; Xue YQ; Wang YJ; Xu P; Sun DK; Chen W
    World Neurosurg; 2019 Mar; 123():e235-e244. PubMed ID: 30496924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Clazosentan After Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis.
    Pontes JPM; Santos MDC; Gibram FC; Rodrigues NMV; Cavalcante-Neto JF; Barros ADM; Solla DJF
    Neurosurgery; 2023 Dec; 93(6):1208-1219. PubMed ID: 37462365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.